Oruka Therapeutics (ORKA) Share-based Compensation (2010 - 2026)
Oruka Therapeutics' quarterly Share-based Compensation came in at $7.0 million in Q1 2026, up 42.7% year-on-year from $4.9 million in Q1 2025, and up 69.33% quarter-over-quarter from $4.1 million in Q4 2025.
Oruka Therapeutics has reported Share-based Compensation for 17 years, with the latest figure at $7.0 million in Q1 2026.
- For the quarter ending Q1 2026, Share-based Compensation rose 42.7% year-over-year to $7.0 million; the trailing twelve-month figure through Mar 2026 stood at $26.3 million (up 33.51% YoY), and the FY2025 full-year result was $24.2 million, up 62.48% from the prior year.
- Share-based Compensation for Q1 2026 stood at $7.0 million, up from $4.1 million in the prior quarter.
- The five-year high for Share-based Compensation was $10.2 million in Q3 2025, with the low at $97000.0 in Q3 2022.
- Average Share-based Compensation over 5 years is $2.8 million, with a median of $204000.0 recorded in 2023.
- Peak annual rise in Share-based Compensation reached 5744.81% in 2024, while the deepest fall reached 50.98% in 2024.
- Tracing ORKA's Share-based Compensation over 5 years: stood at $120000.0 in 2022, then rose by 17.5% to $141000.0 in 2023, then jumped by 3552.48% to $5.1 million in 2024, then fell by 20.1% to $4.1 million in 2025, then soared by 69.33% to $7.0 million in 2026.
- The last three Share-based Compensation figures came in at $7.0 million (Q1 2026), $4.1 million (Q4 2025), and $10.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 892,057.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 305,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 166.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 257.40 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 70.15 Mn |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - | 6.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.97 Mn |
| Mar 31, 2026 | 6.97 Mn |
| Dec 31, 2025 | 4.12 Mn |
| Dec 31, 2025 | 4.12 Mn |
| Sep 30, 2025 | 10.17 Mn |
| Sep 30, 2025 | 10.17 Mn |
| Jun 30, 2025 | 5.08 Mn |
| Jun 30, 2025 | 5.08 Mn |
| Mar 31, 2025 | 4.88 Mn |
| Mar 31, 2025 | 4.88 Mn |
| Dec 31, 2024 | 5.15 Mn |
| Dec 31, 2024 | 5.15 Mn |
| Sep 30, 2024 | 9.00 Mn |
| Sep 30, 2024 | 9.00 Mn |
| Jun 30, 2024 | 683,000.00 |
| Jun 30, 2024 | 683,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | 141,000.00 |
| Dec 31, 2023 | 141,000.00 |
| Sep 30, 2023 | 154,000.00 |
| Sep 30, 2023 | 154,000.00 |
| Jun 30, 2023 | 187,000.00 |
| Jun 30, 2023 | 187,000.00 |
| Mar 31, 2023 | 204,000.00 |
| Mar 31, 2023 | 204,000.00 |
| Dec 31, 2022 | 120,000.00 |
| Dec 31, 2022 | 120,000.00 |
| Sep 30, 2022 | 97,000.00 |
| Sep 30, 2022 | 97,000.00 |
| Jun 30, 2022 | 172,000.00 |
| Jun 30, 2022 | 172,000.00 |
| Mar 31, 2022 | 167,000.00 |
| Mar 31, 2022 | 167,000.00 |
| Dec 31, 2021 | 119,000.00 |
| Dec 31, 2021 | 119,000.00 |
| Sep 30, 2021 | 104,000.00 |
| Sep 30, 2021 | 104,000.00 |
| Jun 30, 2021 | 133,000.00 |
| Jun 30, 2021 | 133,000.00 |
| Mar 31, 2021 | 141,000.00 |
| Mar 31, 2021 | 141,000.00 |
| Dec 31, 2020 | 18,000.00 |
| Dec 31, 2020 | 18,000.00 |
| Sep 30, 2020 | 5,000.00 |
| Sep 30, 2020 | 5,000.00 |
| Jun 30, 2020 | 4,000.00 |
| Jun 30, 2020 | 4,000.00 |
| Mar 31, 2020 | 16,000.00 |
| Mar 31, 2020 | 16,000.00 |
| Dec 31, 2019 | 27,000.00 |
| Dec 31, 2019 | 27,000.00 |
| Sep 30, 2019 | 29,000.00 |
| Sep 30, 2019 | 29,000.00 |
| Jun 30, 2019 | 45,000.00 |
| Jun 30, 2019 | 45,000.00 |
| Mar 31, 2019 | 50,000.00 |
| Mar 31, 2019 | 50,000.00 |
| Dec 31, 2018 | 58,000.00 |
| Dec 31, 2018 | 58,000.00 |
| Sep 30, 2018 | 58,000.00 |
| Sep 30, 2018 | 58,000.00 |
| Jun 30, 2018 | 60,000.00 |
| Jun 30, 2018 | 60,000.00 |
| Mar 31, 2018 | 97,000.00 |
| Mar 31, 2018 | 97,000.00 |
| Dec 31, 2017 | 119,000.00 |
| Dec 31, 2017 | 119,000.00 |
| Sep 30, 2017 | 119,000.00 |
| Sep 30, 2017 | 119,000.00 |
| Jun 30, 2017 | 119,000.00 |
| Jun 30, 2017 | 119,000.00 |
| Mar 31, 2017 | 101,000.00 |
| Mar 31, 2017 | 101,000.00 |
| Dec 31, 2016 | -29,000.00 |
| Dec 31, 2016 | -29,000.00 |
| Sep 30, 2016 | 267,000.00 |
| Sep 30, 2016 | 267,000.00 |
| Jun 30, 2016 | 183,000.00 |
| Jun 30, 2016 | 183,000.00 |
| Mar 31, 2016 | 155,000.00 |
| Mar 31, 2016 | 155,000.00 |
| Dec 31, 2015 | 145,000.00 |
| Dec 31, 2015 | 145,000.00 |
| Sep 30, 2015 | 149,000.00 |
| Sep 30, 2015 | 149,000.00 |
| Jun 30, 2015 | 175,000.00 |
| Jun 30, 2015 | 175,000.00 |
| Mar 31, 2015 | 130,000.00 |
| Mar 31, 2015 | 130,000.00 |
| Dec 31, 2014 | 156,000.00 |
| Dec 31, 2014 | 156,000.00 |
| Sep 30, 2014 | 161,000.00 |
| Sep 30, 2014 | 161,000.00 |
| Jun 30, 2014 | 172,000.00 |
| Jun 30, 2014 | 172,000.00 |
| Mar 31, 2014 | 158,000.00 |
| Mar 31, 2014 | 158,000.00 |
| Dec 31, 2013 | 158,000.00 |
| Dec 31, 2013 | 158,000.00 |
| Sep 30, 2013 | 49,000.00 |
| Sep 30, 2013 | 49,000.00 |
| Jun 30, 2013 | 34,000.00 |
| Jun 30, 2013 | 34,000.00 |
| Mar 31, 2013 | 42,000.00 |
| Mar 31, 2013 | 42,000.00 |
| Dec 31, 2012 | 63,000.00 |
| Dec 31, 2012 | 63,000.00 |
| Sep 30, 2012 | 74,000.00 |
| Sep 30, 2012 | 74,000.00 |
| Jun 30, 2012 | 78,000.00 |
| Jun 30, 2012 | 78,000.00 |
| Mar 31, 2012 | 91,000.00 |
| Mar 31, 2012 | 91,000.00 |
| Dec 31, 2011 | 76,000.00 |
| Dec 31, 2011 | 76,000.00 |
| Sep 30, 2011 | 79,000.00 |
| Sep 30, 2011 | 79,000.00 |
| Jun 30, 2011 | 75,000.00 |
| Jun 30, 2011 | 75,000.00 |
| Mar 31, 2011 | 78,000.00 |
| Mar 31, 2011 | 78,000.00 |
| Dec 31, 2010 | 121,000.00 |
| Dec 31, 2010 | 121,000.00 |
| Sep 30, 2010 | 113,000.00 |
| Sep 30, 2010 | 113,000.00 |